Forgot your password?



Back to login

Digital pill that monitors patients
January 4, 2018, 4:18 pm
Share/Bookmark

The first drug designed to alert a doctor when a patient takes the medication has been approved by The United States Food and Drug Administration (FDA) has for the first time approved a drug that is designed to alert doctors when patients take their medication. The drug, Abilify MyCite has an embedded sensor that sends a message to a wearable patch that the medication has been taken.

This allows the patient and doctor to track the medication’s use via smartphone. Abilify, first approved in 2012, has now been found applicable for treating diseases such as schizophrenia, manic depression and bipolar disorder. The FDA has warned that the drug should not be used to track ‘real-time ingestion’ as the detection period could vary and moreover there was no data so far to prove that Abilify MyCite improved patient compliance with taking medication on a prescribed schedule. Abilify MyCite’s approval was granted to Japan’s Otsuka Pharmaceuticals while the sensor technology and patch will be made Proteus Digital Health, in California.

Share your views
CAPTCHA
 

"It is hard to fail, but it is worse never to have tried to succeed."

"Envy comes from wanting something that isn't yours. But grief comes from losing something you've already had."

Photo Gallery